APC says Trump administration may allow temporary sale of some unapproved peptides
Compounding trade group chief executive Scott Brunner is quoted on the administration's move, which would touch peptides lacking FDA approval.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 8 10:23 ETSource: Alliance for Pharmacy Compounding
The wire
- 01The Alliance for Pharmacy Compounding reports the Trump administration is paving the way for temporary sale of certain unapproved peptides, with APC CEO Scott Brunner quoted.
- 02Compounders, telehealth prescribers and clinicians have been waiting on federal clarity over which peptides may lawfully be dispensed.
- 03Which peptides are covered, the legal mechanism and the duration of any temporary allowance are not specified in the item.
From the source
Read at a4pc.orgTrump administration paving way for temporary sale of some unapproved peptides, and APC's Scott Brunner is quoted
